Related Experiment Video
Updated: Jul 16, 2025

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Investigation of the relationship between monocyte chemoattractant protein 1 rs1024611 variant and severity of
Fatemeh Azarfar1, Bahareh Abbasi2, Amir Jalali1
1Department of Biology, Faculty of Sciences, Arak University, Arak, Iran.
Insights
The Monocyte Chemoattractant Protein 1 (MCP-1) gene polymorphism does not significantly impact Coronavirus disease 2019 (COVID-19) severity. Clinical factors like lower white blood cell counts and elevated liver enzymes are associated with severe COVID-19 outcomes.
Area of Science:
- Immunogenetics
- Virology
- Clinical Medicine
Background:
- Monocyte Chemoattractant Protein 1 (MCP-1) expression is elevated in various conditions.
- Genetic variations in MCP-1 may influence Coronavirus disease 2019 (COVID-19) clinical outcomes.
- Previous studies suggest a potential link between MCP-1 and disease severity.
Purpose of the Study:
- To investigate the association between the MCP-1 -2518A/G (rs1024611) polymorphism and COVID-19 severity.
- To identify clinical and hematological parameters correlated with COVID-19 severity.
Main Methods:
- Genotyping of the MCP-1 rs1024611 (A/G) polymorphism using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP).
- Analysis of biochemical and hematological profiles from 116 patients with varying COVID-19 severity (outpatient, hospitalized, ICU).
Main Results:
- No statistically significant relationship was found between the MCP-1 -2518A/G polymorphism and COVID-19 severity.
- Multivariate analysis indicated that decreased levels of eosinophils, neutrophils, lymphocytes, and monocytes, along with increased levels of SGPT, SGOT, Neutrophil-to-Lymphocyte Ratio (NLR), C-reactive protein (CRP), ferritin, urea, and D-Dimer, were significantly associated with severe COVID-19 (P < 0.05).
Conclusions:
- The MCP-1 gene polymorphism does not appear to influence the severity of COVID-19.
- Further large-scale studies are warranted to validate these findings regarding MCP-1 and COVID-19.
Background:
Higher expression of Monocyte Chemoattractant Protein 1 (MCP-1) was reported in several studies. The clinical severity of Coronavirus disease 2019 (COVID-19) could be affected by genetic polymorphisms in MCP-1. This study aimed to examine the impact of MCP-1 2518A/G polymorphism and clinical parameters with COVID-19 severity.
Methods:
The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method was used for MCP-1 rs1024611 (A/G) genotyping in 116 outpatients, hospitalized, and ICU patients. The biochemical and hematological profiles were collected from the patient's medical records.
Results:
Based on the statistical analysis, there was no significant relationship between the -2518A/G (rs1024611) genetic polymorphism in the regulatory region of the MCP-1 gene and the severity of the COVID-19. Multivariate logistic regression analysis has shown that the severity of COVID-19 infection was associated with decreased levels of eosinophils, neutrophils, lymphocytes, and, monocyte and higher levels of SGPT, SGOT, NLR, CRP, ferritin, urea, and D-Dimer (P < 0.05).
Conclusion:
The MCP-1 gene polymorphism had no impact on COVID-19 severity. However, to confirm these results, a large-scale study needs to be conducted.
More Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...